<DOC>
	<DOCNO>NCT01403051</DOCNO>
	<brief_summary>This study do people infect HIV need start treatment HIV disease . The purpose study see take vitamin D calcium help prevent bone loss sometimes happen people start HIV treatment . For study , follow HIV treatment ( HAART ) provide form single tablet contains three different drug : efavirenz/emtricitabine/tenofovir ( EFV/FTC/TDF ) . These drug approve FDA treat HIV infection . The HIV treatment provide common people take HIV drug first time . The risk see HIV treatment would encounter take drug outside study . The list risk HIV treatment include document drug provide study , drug test . The purpose study look impact high dos vitamin D calcium prevent bone loss . There study objective related HIV treatment ( EFV/FTC/TDF ) .</brief_summary>
	<brief_title>High Dose Vitamin D Calcium Bone Health Individuals Initiating HAART</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Efavirenz , Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>HIV1 infection No evidence exclusionary resistance mutation base result genotype assay laboratory CLIA ( Clinical Laboratory Improvement Amendments ) certification equivalent . Results must available test time past must obtain prior entry review site investigator . ARV drugna√Øve ( &lt; =10 day ART time prior entry ) ARV drug take within past 30 day . CD4+ cell count value obtain within 90 day prior study entry laboratory CLIA certification equivalent . HIV1 RNA &gt; 1000 copies/mL obtain within 90 day prior study entry laboratory CLIA certification equivalent . Certain laboratory value obtain within 30 day prior entry ( indicated section 4.1.6 protocol . Serum calcium &lt; 10.5 mg/dL within 30 day prior entry . For woman reproductive potential , negative serum urine pregnancy test within 48 hour prior initiate study medication . Subjects must refrain participate conception process ( i.e. , active attempt become pregnant impregnate , sperm donation , vitro fertilization ) participate sexual activity could lead pregnancy , subject/partner must use least two reliable form contraceptive list section 4.1.9 protocol . 25OH vitamin D &gt; =10 ng/mL &lt; 75 ng/mL . Ability willingness subject legally authorize representative provide inform consent . Current prior use bisphosphonate therapy . Use vitamin D supplement great 800 IU/day within 30 day prior entry . Use calcium supplement great 500 mg/day within 30 day prior entry . Known allergy/sensitivity hypersensitivity component study drug formulation . Any oral , intravenous , inhaled steroid within 30 day prior enrollment ( intranasal steroid use allow ) . Use androgenic hormone growth hormone . Receipt systemic cytotoxic chemotherapy within 30 day prior entry . Pregnancy currently breastfeed . Documentation acute opportunistic infection within 30 day prior entry . Serious illness require systemic treatment and/or hospitalization subject either complete therapy clinically stable therapy , opinion site investigator , least 7 day prior entry . Weight &gt; 300 lb ( exceeds weight limit DXA scanner ) . History nephrolithiasis ( kidney stone ) . History osteoporosis ( document DXA scan ) fragility fracture . Clinically active thyroid disease ( use thyroid hormone replacement therapy permit TSH must normal range ) . Current imprisonment involuntary incarceration medical facility psychiatric illness . Active drug alcohol use dependence , opinion site investigator , would interfere adherence study requirement . Any condition , opinion site investigator , would compromise subject 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>